Search Reports
Categories
Categories

Global Genetically Engineered Vaccines Market

Global Genetically Engineered Vaccines Market Research Report 2025(Status and Outlook)

Report Code : FBR-HEY2653
Published Date : 17 July, 1905 | No of Pages: 192

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Genetically Engineered Vaccines are a type of vaccine that is developed through the use of genetic engineering techniques. These vaccines involve the manipulation of an organism\'s genetic material to produce a specific protein or antigen that can stimulate an immune response in the body. The process typically involves isolating the gene that codes for the desired antigen, inserting it into a host organism (such as bacteria or yeast), and then culturing the host to produce the antigen in large quantities. The antigen is then purified and used as the active ingredient in the vaccine. This approach allows for the rapid development and production of vaccines, particularly for emerging diseases or those with limited resources. Genetically engineered vaccines can be designed to target specific pathogens, reducing the risk of side effects and enhancing the body\'s immune response. Examples include the hepatitis B vaccine and various COVID-19 vaccines that have been developed using this technology.

This report provides a deep insight into the global Genetically Engineered Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Genetically Engineered Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Genetically Engineered Vaccines market in any manner.
Global Genetically Engineered Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Merck
GSK
Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
Walvax Biotechnology Co.
Ltd.
Bharat Biotech
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co.
Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Santé Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co.
Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.

Market Segmentation (by Type)
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine

Market Segmentation (by Application)
Veterinary Use
Human Use

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genetically Engineered Vaccines Market
Overview of the regional outlook of the Genetically Engineered Vaccines Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genetically Engineered Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Genetically Engineered Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Genetically Engineered Vaccines
      1.2 Key Market Segments
            1.2.1 Genetically Engineered Vaccines Segment by Type
            1.2.2 Genetically Engineered Vaccines Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Genetically Engineered Vaccines Market Overview
      2.1 Global Market Overview
            2.1.1 Global Genetically Engineered Vaccines Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Genetically Engineered Vaccines Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Genetically Engineered Vaccines Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Genetically Engineered Vaccines Product Life Cycle
      3.3 Global Genetically Engineered Vaccines Sales by Manufacturers (2020-2025)
      3.4 Global Genetically Engineered Vaccines Revenue Market Share by Manufacturers (2020-2025)
      3.5 Genetically Engineered Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Genetically Engineered Vaccines Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Genetically Engineered Vaccines Market Competitive Situation and Trends
            3.8.1 Genetically Engineered Vaccines Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Genetically Engineered Vaccines Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Genetically Engineered Vaccines Industry Chain Analysis
      4.1 Genetically Engineered Vaccines Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Genetically Engineered Vaccines Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Genetically Engineered Vaccines Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Genetically Engineered Vaccines Market
      5.7 ESG Ratings of Leading Companies
  6 Genetically Engineered Vaccines Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Genetically Engineered Vaccines Sales Market Share by Type (2020-2025)
      6.3 Global Genetically Engineered Vaccines Market Size Market Share by Type (2020-2025)
      6.4 Global Genetically Engineered Vaccines Price by Type (2020-2025)
  7 Genetically Engineered Vaccines Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Genetically Engineered Vaccines Market Sales by Application (2020-2025)
      7.3 Global Genetically Engineered Vaccines Market Size (M USD) by Application (2020-2025)
      7.4 Global Genetically Engineered Vaccines Sales Growth Rate by Application (2020-2025)
  8 Genetically Engineered Vaccines Market Sales by Region
      8.1 Global Genetically Engineered Vaccines Sales by Region
            8.1.1 Global Genetically Engineered Vaccines Sales by Region
            8.1.2 Global Genetically Engineered Vaccines Sales Market Share by Region
      8.2 Global Genetically Engineered Vaccines Market Size by Region
            8.2.1 Global Genetically Engineered Vaccines Market Size by Region
            8.2.2 Global Genetically Engineered Vaccines Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Genetically Engineered Vaccines Sales by Country
            8.3.2 North America Genetically Engineered Vaccines Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Genetically Engineered Vaccines Sales by Country
            8.4.2 Europe Genetically Engineered Vaccines Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Genetically Engineered Vaccines Sales by Region
            8.5.2 Asia Pacific Genetically Engineered Vaccines Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Genetically Engineered Vaccines Sales by Country
            8.6.2 South America Genetically Engineered Vaccines Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Genetically Engineered Vaccines Sales by Region
            8.7.2 Middle East and Africa Genetically Engineered Vaccines Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Genetically Engineered Vaccines Market Production by Region
      9.1 Global Production of Genetically Engineered Vaccines by Region(2020-2025)
      9.2 Global Genetically Engineered Vaccines Revenue Market Share by Region (2020-2025)
      9.3 Global Genetically Engineered Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Genetically Engineered Vaccines Production
            9.4.1 North America Genetically Engineered Vaccines Production Growth Rate (2020-2025)
            9.4.2 North America Genetically Engineered Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Genetically Engineered Vaccines Production
            9.5.1 Europe Genetically Engineered Vaccines Production Growth Rate (2020-2025)
            9.5.2 Europe Genetically Engineered Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Genetically Engineered Vaccines Production (2020-2025)
            9.6.1 Japan Genetically Engineered Vaccines Production Growth Rate (2020-2025)
            9.6.2 Japan Genetically Engineered Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Genetically Engineered Vaccines Production (2020-2025)
            9.7.1 China Genetically Engineered Vaccines Production Growth Rate (2020-2025)
            9.7.2 China Genetically Engineered Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Pfizer
            10.1.1 Pfizer Basic Information
            10.1.2 Pfizer Genetically Engineered Vaccines Product Overview
            10.1.3 Pfizer Genetically Engineered Vaccines Product Market Performance
            10.1.4 Pfizer Business Overview
            10.1.5 Pfizer SWOT Analysis
            10.1.6 Pfizer Recent Developments
      10.2 Merck
            10.2.1 Merck Basic Information
            10.2.2 Merck Genetically Engineered Vaccines Product Overview
            10.2.3 Merck Genetically Engineered Vaccines Product Market Performance
            10.2.4 Merck Business Overview
            10.2.5 Merck SWOT Analysis
            10.2.6 Merck Recent Developments
      10.3 GSK
            10.3.1 GSK Basic Information
            10.3.2 GSK Genetically Engineered Vaccines Product Overview
            10.3.3 GSK Genetically Engineered Vaccines Product Market Performance
            10.3.4 GSK Business Overview
            10.3.5 GSK SWOT Analysis
            10.3.6 GSK Recent Developments
      10.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
            10.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information
            10.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Overview
            10.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Genetically Engineered Vaccines Product Market Performance
            10.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Business Overview
            10.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments
      10.5 Walvax Biotechnology Co.
            10.5.1 Walvax Biotechnology Co. Basic Information
            10.5.2 Walvax Biotechnology Co. Genetically Engineered Vaccines Product Overview
            10.5.3 Walvax Biotechnology Co. Genetically Engineered Vaccines Product Market Performance
            10.5.4 Walvax Biotechnology Co. Business Overview
            10.5.5 Walvax Biotechnology Co. Recent Developments
      10.6 Ltd.
            10.6.1 Ltd. Basic Information
            10.6.2 Ltd. Genetically Engineered Vaccines Product Overview
            10.6.3 Ltd. Genetically Engineered Vaccines Product Market Performance
            10.6.4 Ltd. Business Overview
            10.6.5 Ltd. Recent Developments
      10.7 Bharat Biotech
            10.7.1 Bharat Biotech Basic Information
            10.7.2 Bharat Biotech Genetically Engineered Vaccines Product Overview
            10.7.3 Bharat Biotech Genetically Engineered Vaccines Product Market Performance
            10.7.4 Bharat Biotech Business Overview
            10.7.5 Bharat Biotech Recent Developments
      10.8 Sanofi
            10.8.1 Sanofi Basic Information
            10.8.2 Sanofi Genetically Engineered Vaccines Product Overview
            10.8.3 Sanofi Genetically Engineered Vaccines Product Market Performance
            10.8.4 Sanofi Business Overview
            10.8.5 Sanofi Recent Developments
      10.9 Zoties
            10.9.1 Zoties Basic Information
            10.9.2 Zoties Genetically Engineered Vaccines Product Overview
            10.9.3 Zoties Genetically Engineered Vaccines Product Market Performance
            10.9.4 Zoties Business Overview
            10.9.5 Zoties Recent Developments
      10.10 Elanco
            10.10.1 Elanco Basic Information
            10.10.2 Elanco Genetically Engineered Vaccines Product Overview
            10.10.3 Elanco Genetically Engineered Vaccines Product Market Performance
            10.10.4 Elanco Business Overview
            10.10.5 Elanco Recent Developments
      10.11 Boehringer Ingelheim
            10.11.1 Boehringer Ingelheim Basic Information
            10.11.2 Boehringer Ingelheim Genetically Engineered Vaccines Product Overview
            10.11.3 Boehringer Ingelheim Genetically Engineered Vaccines Product Market Performance
            10.11.4 Boehringer Ingelheim Business Overview
            10.11.5 Boehringer Ingelheim Recent Developments
      10.12 Indian Immunologicals
            10.12.1 Indian Immunologicals Basic Information
            10.12.2 Indian Immunologicals Genetically Engineered Vaccines Product Overview
            10.12.3 Indian Immunologicals Genetically Engineered Vaccines Product Market Performance
            10.12.4 Indian Immunologicals Business Overview
            10.12.5 Indian Immunologicals Recent Developments
      10.13 China Animal Husbandry Industry Co.,Ltd.
            10.13.1 China Animal Husbandry Industry Co.,Ltd. Basic Information
            10.13.2 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Overview
            10.13.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines Product Market Performance
            10.13.4 China Animal Husbandry Industry Co.,Ltd. Business Overview
            10.13.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments
      10.14 Yebio Bioengineering Co.
            10.14.1 Yebio Bioengineering Co. Basic Information
            10.14.2 Yebio Bioengineering Co. Genetically Engineered Vaccines Product Overview
            10.14.3 Yebio Bioengineering Co. Genetically Engineered Vaccines Product Market Performance
            10.14.4 Yebio Bioengineering Co. Business Overview
            10.14.5 Yebio Bioengineering Co. Recent Developments
      10.15 Ltd Of Qingdao
            10.15.1 Ltd Of Qingdao Basic Information
            10.15.2 Ltd Of Qingdao Genetically Engineered Vaccines Product Overview
            10.15.3 Ltd Of Qingdao Genetically Engineered Vaccines Product Market Performance
            10.15.4 Ltd Of Qingdao Business Overview
            10.15.5 Ltd Of Qingdao Recent Developments
      10.16 Jinyu Bio-technology Co.,ltd.
            10.16.1 Jinyu Bio-technology Co.,ltd. Basic Information
            10.16.2 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Overview
            10.16.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines Product Market Performance
            10.16.4 Jinyu Bio-technology Co.,ltd. Business Overview
            10.16.5 Jinyu Bio-technology Co.,ltd. Recent Developments
      10.17 HVRI
            10.17.1 HVRI Basic Information
            10.17.2 HVRI Genetically Engineered Vaccines Product Overview
            10.17.3 HVRI Genetically Engineered Vaccines Product Market Performance
            10.17.4 HVRI Business Overview
            10.17.5 HVRI Recent Developments
      10.18 Ringpu Biology
            10.18.1 Ringpu Biology Basic Information
            10.18.2 Ringpu Biology Genetically Engineered Vaccines Product Overview
            10.18.3 Ringpu Biology Genetically Engineered Vaccines Product Market Performance
            10.18.4 Ringpu Biology Business Overview
            10.18.5 Ringpu Biology Recent Developments
      10.19 Kyoto Biken Laboratories
            10.19.1 Kyoto Biken Laboratories Basic Information
            10.19.2 Kyoto Biken Laboratories Genetically Engineered Vaccines Product Overview
            10.19.3 Kyoto Biken Laboratories Genetically Engineered Vaccines Product Market Performance
            10.19.4 Kyoto Biken Laboratories Business Overview
            10.19.5 Kyoto Biken Laboratories Recent Developments
      10.20 FATRO
            10.20.1 FATRO Basic Information
            10.20.2 FATRO Genetically Engineered Vaccines Product Overview
            10.20.3 FATRO Genetically Engineered Vaccines Product Market Performance
            10.20.4 FATRO Business Overview
            10.20.5 FATRO Recent Developments
      10.21 Ceva Santé Animale
            10.21.1 Ceva Santé Animale Basic Information
            10.21.2 Ceva Santé Animale Genetically Engineered Vaccines Product Overview
            10.21.3 Ceva Santé Animale Genetically Engineered Vaccines Product Market Performance
            10.21.4 Ceva Santé Animale Business Overview
            10.21.5 Ceva Santé Animale Recent Developments
      10.22 Pulike Biological Engineering,Inc.
            10.22.1 Pulike Biological Engineering,Inc. Basic Information
            10.22.2 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Overview
            10.22.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines Product Market Performance
            10.22.4 Pulike Biological Engineering,Inc. Business Overview
            10.22.5 Pulike Biological Engineering,Inc. Recent Developments
      10.23 Wuhan Hvsen Biotechnology CO.,LTD
            10.23.1 Wuhan Hvsen Biotechnology CO.,LTD Basic Information
            10.23.2 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Overview
            10.23.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines Product Market Performance
            10.23.4 Wuhan Hvsen Biotechnology CO.,LTD Business Overview
            10.23.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments
      10.24 Jinhe Biotechnology Co.
            10.24.1 Jinhe Biotechnology Co. Basic Information
            10.24.2 Jinhe Biotechnology Co. Genetically Engineered Vaccines Product Overview
            10.24.3 Jinhe Biotechnology Co. Genetically Engineered Vaccines Product Market Performance
            10.24.4 Jinhe Biotechnology Co. Business Overview
            10.24.5 Jinhe Biotechnology Co. Recent Developments
      10.25 Ltd.
            10.25.1 Ltd. Basic Information
            10.25.2 Ltd. Genetically Engineered Vaccines Product Overview
            10.25.3 Ltd. Genetically Engineered Vaccines Product Market Performance
            10.25.4 Ltd. Business Overview
            10.25.5 Ltd. Recent Developments
      10.26 Shanghai Shen Lian Biomedical Corporation
            10.26.1 Shanghai Shen Lian Biomedical Corporation Basic Information
            10.26.2 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Overview
            10.26.3 Shanghai Shen Lian Biomedical Corporation Genetically Engineered Vaccines Product Market Performance
            10.26.4 Shanghai Shen Lian Biomedical Corporation Business Overview
            10.26.5 Shanghai Shen Lian Biomedical Corporation Recent Developments
      10.27 Qingdao Vland Biotech INC.
            10.27.1 Qingdao Vland Biotech INC. Basic Information
            10.27.2 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Overview
            10.27.3 Qingdao Vland Biotech INC. Genetically Engineered Vaccines Product Market Performance
            10.27.4 Qingdao Vland Biotech INC. Business Overview
            10.27.5 Qingdao Vland Biotech INC. Recent Developments
  11 Genetically Engineered Vaccines Market Forecast by Region
      11.1 Global Genetically Engineered Vaccines Market Size Forecast
      11.2 Global Genetically Engineered Vaccines Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Genetically Engineered Vaccines Market Size Forecast by Country
            11.2.3 Asia Pacific Genetically Engineered Vaccines Market Size Forecast by Region
            11.2.4 South America Genetically Engineered Vaccines Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Genetically Engineered Vaccines by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Genetically Engineered Vaccines Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Genetically Engineered Vaccines by Type (2026-2033)
            12.1.2 Global Genetically Engineered Vaccines Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Genetically Engineered Vaccines by Type (2026-2033)
      12.2 Global Genetically Engineered Vaccines Market Forecast by Application (2026-2033)
            12.2.1 Global Genetically Engineered Vaccines Sales (K MT) Forecast by Application
            12.2.2 Global Genetically Engineered Vaccines Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Pfizer
Merck
GSK
Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
Walvax Biotechnology Co.
Ltd.
Bharat Biotech
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co.
Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Santé Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co.
Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400